期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Frontiers in Immunology LetPub Score 7.9
51 ratings
Rate
Reputation 7.8 Influence 7.3 Speed 8.5 | ||||||||||||||||||||
期刊簡稱 | FRONT IMMUNOL | ||||||||||||||||||||
ISSN | 1664-3224 | ||||||||||||||||||||
h-index | 84 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 8.80%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://journal.frontiersin.org/journal/immunology | ||||||||||||||||||||
在線稿件提交 | http://www.frontiersin.org/submission/submissioninfo.aspx | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Frontiers Media S.A. | ||||||||||||||||||||
主題領域 | IMMUNOLOGY | ||||||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 5971每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 99.67% | ||||||||||||||||||||
OA Related Info | APC: Yes( USD3295; ) APC waiver:Check Notes Other charges: No Keywords: immunology、adaptive immunity、innate immunity、clinical immunology、molecular immunology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3224%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 14 Weeks | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[Frontiers in Immunology] 的評論 | 撰寫評論 |
作者: 今天下雨 領域: 医学 審稿時間: 3.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-06-17 23:30:48 評論於 Why is the proportion of Chinese people so high in this publication?!(0) 讚! | 今天下雨 |
作者: drliao 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-17 20:25:17 評論於 Submitted on May 4th, also received reviews from two reviewers, with similar scores to yours. Still haven't heard any news until now, not sure if there is still hope(0) 讚! | drliao |
作者: 德云小生 領域: 农林科学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-06-15 22:06:10 評論於 Your score is pretty good, steady!(0) 讚! | 德云小生 |
作者: 多纳泰罗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-11 15:04:22 評論於 FI 20240516 Submission 20240517 EA 20240527 Independent Review 20240604-20240605 Received comments from two reviewers. One 3333 and one 4444. Any more reviews? Not yet entered Interactive Review. Display still shows "Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready." Review is ongoing. Seeking clarification. Is this normal? Does it indicate rejection?(1) 讚! | 多纳泰罗 |
作者: zhouting? 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-06 14:35:43 評論於 Don't give up(0) 讚! | zhouting? |
作者: 小蜗牛 領域: 医学 審稿時間: 7.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-05-31 12:38:32 評論於 The quality requirements have significantly improved, with a high rate of rejections. The reviewers are professional and take a long time in reviewing. The editors are very responsible, and hope to increase the influence of the journal(0) 讚! | 小蜗牛 |
作者: 小蜗牛 領域: 医学 審稿時間: 7.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-05-31 12:34:27 評論於 17 Jan 2024 Interactive review forum activated. 23 May 2024 Article accepted for publication(0) 讚! | 小蜗牛 |
作者: 小野寺静安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-27 21:40:12 評論於 Please translate the following paragraph into English and Japanese, and title them as ":" and ":"(0) 讚! | 小野寺静安 |
作者: 王拽拽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-23 10:23:48 評論於 I am also in the revision stage and have added the author. May I ask what is the current situation on your end? I have been on the manuscript reply interface for over a month(0) 讚! | 王拽拽 |
作者: 123ccr 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-05-23 08:17:53 評論於 I will never forget the time we spent together, the laughter we shared, and the memories we created. Thank you for all the love and happiness you brought into my life(0) 讚! | 123ccr |
作者: 灵空经业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-20 21:31:59 評論於 Afterwards, what happened?(0) 讚! | 灵空经业 |
作者: Joanne Leopold 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-20 15:04:32 評論於 It's really hard to write articles now(0) 讚! | Joanne Leopold |
作者: 销魂星辰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-20 11:47:58 評論於 It's very difficult(0) 讚! | 销魂星辰 |
作者: 中原冠英 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-19 22:12:04 評論於 Dengle for two months and still inactive(0) 讚! | 中原冠英 |
作者: zhouting? 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-18 22:13:53 評論於 Is it not possible to provide an explanation to the editor, along with the authorship change form and signatures from all authors, given that we have already reached the final validation stage?(0) 讚! | zhouting? |
作者: 小小小钻风 領域: 医学 審稿時間: 4.0 month(s) 結果: 拒稿 撰寫評論 |
2024-05-18 17:48:16 評論於 This is a major taboo. The editor-in-chief of Frontiers magazine has specifically commented on this. It's best to decide on the author from the beginning and not change it later(0) 讚! | 小小小钻风 |
作者: zhouting? 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-17 21:15:47 評論於 Have you ever had the experience of changing an author's work during the submission process? Is this considered a big taboo at Frontiers? What should we pay attention to?(0) 讚! | zhouting? |
作者: Joanne Leopold 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-16 20:54:13 評論於 Mendel is very unfriendly now(0) 讚! | Joanne Leopold |
作者: 宫古秋旺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-15 21:14:41 評論於 Are you not uploading the original data?(0) 讚! | 宫古秋旺 |
作者: Joanne Leopold 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-14 10:14:40 評論於 Can Mendel still send messages?(0) 讚! | Joanne Leopold |
作者: 灵空经业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-12 20:32:11 評論於 I have been a distribution editor for over a month, but there has been no progress. I don't know what's going on(0) 讚! | 灵空经业 |
作者: Sampson Whitman 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-09 22:24:00 評論於 Research Focus: Immunology; Inflammation Experience Sharing: Just got a paper accepted, took a total of 4 months. Two major revisions, and the editor made a minor revision at the end. Everyone says it's pretty ordinary, but it feels quite formal. Because of the large amount of publications, even if the impact is small, they are willing to give opportunities. This is the significance of cutting-edge research, right?(0) 讚! | Sampson Whitman |
作者: 巴蜀旭鹏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-29 15:50:22 評論於 It's been a month, what's going on?(0) 讚! | 巴蜀旭鹏 |
作者: 巴蜀旭鹏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-27 21:08:17 評論於 It's been almost a month since I reinvested in IV after four days of withdrawal(0) 讚! | 巴蜀旭鹏 |
作者: 排云夜香 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-21 11:14:16 評論於 Mendel submitted on Saturday, and was rejected on Monday(0) 讚! | 排云夜香 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us